Overturning of Molecular Test Coverage Denials Varies Widely, According to UCSF Study
Research into independent medical review data in four states show payers’ internal policies affect rates of overturns
Research into independent medical review data in four states show payers’ internal policies affect rates of overturns
Better clinical laboratory test data reporting would allow ‘Medicare rates to be more appropriately set,’ says Susan Van Meter
Bill that ended government shutdown includes provision to hold off PAMA cuts
How clinical laboratories should prepare for the next wave of oversight in the new year
However, a proposed bill called the RESULTS Act is racing to thwart the cuts to lab test reimbursement rates
Government reform and payer streamlining may reduce the burden on healthcare providers, but laboratories should remain vigilant
Two revenue cycle management experts explain opportunities that clinical laboratories have with artificial intelligence
Clinical lab billing teams face an overwhelming number of challenges if revenue cycle strategies fall short
The free online tool can set a foundation for renewed reimbursement strategies and contract negotiations with insurance carriers
The proposed PFS rule also includes other changes that will affect physician, lab, and other reimbursements in 2024 and beyond.
Here’s what to know about the new codes that CMS recently added to the national HCPCS table as well as which ones were removed.